PERRIGO (PRGO) Stock: Buy, Sell, or Hold?
$16.55
-0.28 (-1.66%)
▼
5d:
+4.55%
30d:
+7.68%
90d:
+28.99%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect PRGO Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (27%)
Quality Score
34/100
Position
EXTENDED
30-Day Fair Range
$15.06 – $16.48
Position: EXTENDED
Forward P/E & Valuation
7.2x
STRETCHED
vs 5.2x historical avg
Wall Street Target
$18.00
+8.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$15.12 / $17.02
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: PRGO shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When PRGO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.38
Based on 0.8% avg growth
INTRINSIC VALUE TODAY
$7.68
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PRGO is currently trading at $16.55, which is considered extended relative to its 30-day fair value range of $15.06 to $16.48. From a valuation perspective, the stock is trading at a premium (Forward PE: 7.2) compared to its historical average (5.2). At these levels, the market is pricing in 11.8% annual earnings growth.
Technical Outlook: Technically, PRGO is in a strong uptrend. The price is approaching resistance at $17.02. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PRGO scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRGO is in a strong uptrend. The price is approaching resistance at $17.02. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PRGO scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$15.06 -
$16.48
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
27.1%
Trading Range & Key Levels
30-Day Trading Range
$15.06 -
$16.48
Current vs Trading Range
EXTENDED
Support Level
$15.12
Resistance Level
$17.02
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding PRGO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($18.00)
- BULLISH: Expecting earnings turnaround to 11.8% growth with -5.2% revenue growth
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
7.21
Wall Street Target
$18.00
(+8.8%)
Revenue Growth (YoY)
-5.2%
Earnings Growth (YoY)
-63.6%
Profit Margin
-43.3%
Valuation Premium vs History
+11.8% premium
PE vs Historical
7.2 vs 5.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.8%
(market-implied from PE analysis)
1-Year Target
$18.50
(+12%)
2-Year Target
$20.69
(+25%)
3-Year Target
$23.13
(+40%)
3-Yr Target (if PE normalizes)
(PE: 7→5)
PE COMPRESSION
$16.68
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: -2.5%)
$42.30
(+156%)
Base:
(SPY PE: 7.2, Growth: -2.5%)
$15.35
(-7%)
Bear:
(PE: 5.2, Growth: -2.5%)
$11.08
(-33%)
Share PRGO Analysis
Share this live PRGO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PRGO)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 23, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message congratulates investors for purchasing $PRGO shares below 16.
Key Retail Themes:
Share price appreciation
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:30 PM ET
Data refreshes hourly during market hours. Next update: 8:30 PM
Data refreshes hourly during market hours. Next update: 8:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRGO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 33 SELL |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$687 | 52 HOLD |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 53 HOLD |
Advanced PRGO Option Strategies
Professional options setups generated by AI based on today's PRGO price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PRGO Research Pages
